Figure 2.
Role of D1R and NMDAR in the cocaine-induced blockade of eCB-LTD. a, Cocaine-induced inhibition of eCB-LTD was prevented by a D1R antagonist. Animals that had received SCH23390 (0.5 mg/kg) displayed eCB-LTD when coinjected with cocaine (n = 9; ***p < 0.05 compared with cocaine alone). D1R -/- mice display normal eCB-LTD (n = 7) but were insensitive to cocaine administration compared with wild type (n = 9; ***p < 0.05). The dashed line represents 100%. b, Representative Western blots of animals administered saline (sham), SCH23390 (SCH; 0.5 mg/kg) alone, or SCH23390 plus cocaine (SCH + Coc) in vivo. The blots show protein levels for CC-Homer using a pan-Homer antibody in the NAc 1 d after injection. Densitometry measurements are expressed as percentage of control ± SEM. In SCH23390-injected animals, single cocaine exposure (n = 6) did not alter CC-Homer protein levels in the NAc, compared with saline (n = 5; p > 0.05) and SCH23390 alone (n = 6; p > 0.05). c, Cocaine-induced inhibition of eCB-LTD is prevented by an NMDAR antagonist. Animals receiving MK801 display normal eCB-LTD when coinjected with cocaine (n = 13; ***p < 0.05 compared with cocaine alone). The dashed line represents 100%. d, Representative Western blots of animals administered saline (sham), MK801 (1 mg/kg) alone, or MK801 plus cocaine (MK801 + Coc) in vivo. The blots show protein levels for CC-Homer using a pan-Homer antibody in the NAc 1 d after injection. Densitometry measurements are expressed as percentage of control ± SEM. In MK801-injected animals, single cocaine exposure (n = 8) did not alter CC-Homer protein levels in the NAc, compared with saline (n = 8; p > 0.05) and MK801 alone (n = 8; p > 0.05).